Covetrus Launches New Platform Application to Drive Proactive Prescription Management
Covetrus Script Assist helps veterinarians enhance patient compliance
Covetrus Script Assist leverages machine learning and practice management records to quickly identify where gaps in medical care reside, particularly in areas like preventative medications. Once a prescription is "created," the veterinarian or delegate will have minimal steps in order to get a prescription to the client for fulfillment on their storefront.
“Veterinarians continue to face challenges balancing the on-demand needs of today’s consumer with the focus on delivering outstanding clinical care,” said
Signature features of Covetrus Script Assist include:
- Systematic prescribing of preventatives - Veterinarians can proactively prescribe preventatives for patients with past or upcoming appointments that have not purchased any product within the last 18 months.
- Reduced steps for issuing prescriptions - Once a proactive prescription has been “created” the veterinarian or delegate will have just a few steps in order to get a prescription to the client for fulfillment on their storefront.
- More informed compliance monitoring - The ability to quickly prescribe preventatives will drive practices closer to compliance and keep their patients healthy.
"Script Assist has simplified our prescribing process and improved our workflow," said
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. For more information about
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the